Investigational PerQseal Blue designed to be the world’s first and only fully absorbable device for large-bore venous closure Development program funded by €2.5 million grant awarded by the European Innovation Council Accelerator GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development […]
Author: Ken Dropiewski
Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate
ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q2 2021. Thomas Sandgaard, CEO of Zynex said: “Our […]
BioCardia Announces Japanese Patent on Imaging System for Targeting Cardiac Therapies
SAN CARLOS, Calif., July 15, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Japan Patent Office has granted Patent No: 6887216 titled, “Target Site Selection, Entry, and Update With Automatic Remote Image […]
Acutus Medical, Inc. Announces Pricing of Public Offering of Common Stock
CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $14.00 per share. All of the shares of common stock are being offered […]
HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company
Transforming the way heart disease is diagnosed and treated, HeartFlow’s artificial intelligence-enabled software platform brings precision heart care to cardiology. The HeartFlow Analysis is the first and only non-invasive tool to assist with the diagnosis, management and treatment of patients with heart disease, the most common type of cardiovascular disease […]
MedAxiom Announces Industry Partnership with Vector Remote Care
Vector Provides the Expert, Timely Cardiac Insights that Clinics Need to Deliver the Highest Level of Care NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, the nation’s leading cardiovascular healthcare membership organization and performance community, is excited to announce its industry partnership with Vector Remote Care, a complete cardiac remote monitoring solution that makes it simple […]
CARMAT Announces the First Human Implant of Its Total Artificial Heart in the United States
The implant was performed at Duke University Hospital, one of the largest U.S. cardiology centers PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage […]
Viz.ai and Avicenna.AI Partner to Launch World-class AI-Driven Intelligent Care Coordination for Pulmonary Embolism and Aortic Disease
SAN FRANCISCO & PARIS–(BUSINESS WIRE)–Viz.ai, the world leader in AI-driven intelligent care coordination, has partnered with Avicenna.AI, a global leader in artificial intelligence solutions, to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease. The collaboration will pave the way for faster […]
Imperative Care Raises $260 Million to Advance Innovations that Elevate Stroke Care
Imperative Care to Create Strategic Network of Wholly Owned Development Subsidiaries in Areas of Synergy, Starting with Acquisition of Truvic Medical, Inc., a Peripheral Thrombectomy Innovator CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has closed a $260 million Series D financing led by D1 Capital Partners L.P. New investors […]
OneProjects, VistaMed and Tyndall Institute Awarded Funding to Improve Treatment of Cardiac Arrhythmias
CARRICK-ON-SHANNON, Ireland–(BUSINESS WIRE)–VistaMed, a Freudenberg Medical company and leading CDMO for complex extrusions, finished catheters, and medical devices for minimally invasive applications, is pleased to announce that they are part of a team that has been awarded €5.1 million over a three-year period for a project that aims to provide […]



